Baysal Ayse, Polat Tugcin Bora, Yalcin Yalim, Celebi Ahmet
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Hospital, 45 ADA Mimoza 1a D:15, Atasehir, Istanbul, Turkey.
Cardiol Young. 2008 Feb;18(1):51-7. doi: 10.1017/S1047951107001679. Epub 2007 Dec 20.
We investigated the use of the bispectral index for monitoring sedation during cardiac catheterization. The scores for the bispectral index may not reflect correct values in children, but may be helpful during titration of sedatives such as midazolam and ketamine.
We conducted a prospective randomized clinical trial in 126 patients scheduled for cardiac catheterization in a teaching hospital. They ranged in age from 4 months to 15 years. In 66 patients, sedation was performed without use of the bispectral index, while the index was used in the other 60 patients. The data collected included heart rate, mean arterial pressure, respiratory rate, saturation of oxygen, amount of sedatives, awakening time and adverse effects. We subdivided the patients into age-related groups for each parameter.
The demographic data were not statistically different. Monitoring with the bispectral index in those aged from 1 to 3 years revealed use of lower doses of midazolam, at 2.09 mg per kg per hr, with standard deviation of 0.36, and similarly lowers doses of ketamine, at 2.07 mg per kg per hr, with standard deviation of 0.22, the values in those not monitored being 2.93, with standard deviation of 0.45, and 2.96 with standard deviation of 0.51 respectively, these difference being statistically significant (p = 0.001 and p = 0.04, respectively). In those aged from 3 to 6 years of age, dosage of midazolam was 2.09, with deviation of 0.36, and of ketamine 1.78, with deviation of 0.27, following use of the bispectral index, compared to 2.89 with deviation of 0.28, and 2.62 with deviation of 0.69 respectively, when the bispectral index was not used, these again being significant differences (p = 0.033 and p = 0.04). The requirements for respiratory support and adverse effects were also significantly lower when using the bispectral index (p less than 0.05). No significant difference was found regarding dosages at the ages of 4 months to 1 year, and 6 to 15 years. The awakening time, however, was shorter with use of the index in those aged from 1 to 6 years.
When using the bispectral index for monitoring sedation during catheterization in children, we noted decreased need for doses of midazolam and ketamine, a lower need for respiratory support and less adverse effects.
我们研究了脑电双频指数在心脏导管插入术期间监测镇静作用的应用。脑电双频指数的评分可能无法反映儿童的正确数值,但在滴定咪达唑仑和氯胺酮等镇静剂时可能会有所帮助。
我们在一家教学医院对126例计划进行心脏导管插入术的患者进行了一项前瞻性随机临床试验。他们的年龄从4个月到15岁不等。66例患者在不使用脑电双频指数的情况下进行镇静,而另外60例患者使用该指数。收集的数据包括心率、平均动脉压、呼吸频率、血氧饱和度、镇静剂用量、苏醒时间和不良反应。我们将患者按年龄分组以分析每个参数。
人口统计学数据无统计学差异。在1至3岁的患者中使用脑电双频指数监测显示,咪达唑仑的用量较低,为每千克每小时2.09毫克,标准差为0.36,氯胺酮的用量同样较低,为每千克每小时2.07毫克,标准差为0.22,未进行监测的患者中咪达唑仑用量为2.93,标准差为0.45,氯胺酮用量为2.96,标准差为0.51,这些差异具有统计学意义(分别为p = 0.001和p = 0.04)。在3至6岁的患者中,使用脑电双频指数后咪达唑仑用量为2.09,标准差为0.36,氯胺酮用量为1.78,标准差为0.27,而未使用脑电双频指数时,咪达唑仑用量为2.89,标准差为0.28,氯胺酮用量为2.62,标准差为0.69,这些同样是显著差异(p = 0.033和p = 0.04)。使用脑电双频指数时,呼吸支持需求和不良反应也显著更低(p小于0.05)。在4个月至1岁以及6至15岁的患者中,用量无显著差异。然而,在1至6岁的患者中使用该指数时苏醒时间更短。
在儿童导管插入术期间使用脑电双频指数监测镇静时,我们注意到咪达唑仑和氯胺酮的用量需求减少,呼吸支持需求降低,不良反应减少。